Clinical Trial

A Study to Learn About Litfulo Capsule in People With Severe Alopecia Areata in Routine Clinical Practice.

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this observation study is to learn about the safety and effects of the study medicine (called Litfulo) for the potential treatment of Severe Alopecia Areata.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-08-25; most recent amendment 2026-05-14.
Status change: Not Yet Recruiting → Recruiting 2025-11-17
Trial Details
NCT Number NCT07152119
Lead Sponsor Pfizer
Conditions Severe Alopecia Areata
Enrollment 3,000 participants
Start Date 2025-08-27
Primary Completion 2030-03-23 (estimated)
Study Completion 2030-03-23 (estimated)
Updated on ClinicalTrials.gov 2026-05-18